Projects per year
Search results
-
Active
A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in People With Celiac Disease
Brown, G.
4/09/23 → 4/09/25
Project: Research
-
FAD-UC: Investigating the therapeutic potential of a diet low in sulphite- & carrageenan food additives for ulcerative colitis
Yao, C., Gibson, P., Biesiekierski, J., Halmos, E., Fitzpatrick, J. W. & Ardalan, Z.
1/09/23 → 30/11/24
Project: Research
-
An Open-Label Phase 1b Study Evaluating the Safety, Tolerability, Immunogenicity and Antiviral Activity of Multiple Doses of CLB-3000 in Subjects with Chronic Hepatitis B
Roberts, S. & McKenzie, J.
2/08/23 → 1/08/25
Project: Research
-
Dissecting the role of group 2 innate lymphoid cells in gastric cancer
Buchert, M., Eissman, M. F., Locksley, R., Ernst, M., Li, X., Boussioutas, A., Shi, W., Lee, J. & Pal, B.
1/01/23 → 31/12/26
Project: Research
-
HER2 testing in advanced gastric cancer – understanding and reducing variation in current practice to improve patient survival
Ioannou, L., Zalcberg, J., Boussioutas, A., Fox, S. B., Duong, C. P., Wong, R., Chen, R., Haydon, A., Graco, M., Saxon, S., Ananda, S. S., Tagkalidis, P., Lipton, L. R., Brown, S. B., Aga, A., Hair, C. S. & Tawfik, B.
4/04/22 → 7/04/25
Project: Research
-
The role of a low emulsifier diet in treating Crohn's disease
Halmos, E. & Fitzpatrick, J. W.
1/02/22 → 23/01/24
Project: Research
-
AGITG TOP GEAR: A randomised phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer
Leong, T., Smithers, B., Lordick, F., Simes, R. J., Darling, G. E., Gebski, V. J., Boussioutas, A., Haustermans, K. M. G., Zalcberg, J. & Michael, M. Z.
1/07/21 → 30/06/26
Project: Research
-
A Multicentre, Observational, Phase 4 Study to Evaluate the Safety and Tolerability of Lenvatinib in Patients with Advanced or Unresectable Hepatocellular Carcinoma (STELLAR)
Roberts, S. & Lewis, P.
28/05/21 → 31/12/27
Project: Research
-
Using dietary therapy to slow the progression of diabetic kidney disease
Snelson, M., Coughlan, M., Ekinci, E., Baqar, S., Muir, J. & Kellow, N.
3/05/21 → 31/12/24
Project: Research
-
-
A randomized, double-blind, dose-ranging, placebo-controlled, Phase 2a evaluation of the safety, tolerability, and pharmacokinetics of PLN 74809 in participants with primary sclerosing cholangitis (PSC) and suspected liver fibrosis (INTEGRIS-PSC).
Roberts, S., Adams, L. A., George, J., Strasser, S. I., Thompson, A. J. V. & Lynch, K. D.
1/10/20 → 1/11/23
Project: Research
-
A Phase 3 Multicenter, Randomized, Double-blinded, Active-controlled, Clinical Study to Evaluate the Safety and Efficacy of Lenvatinib (E7080/MK-7902) with Pembrolizumab (MK-3475) in Combination with Transarterial Chemoembolization (TACE) Versus TACE in Participants with Incurable/Non-metastatic Hepatocellular Carcinoma (LEAP-012).
Roberts, S. & Lewis, P.
5/06/20 → 31/12/23
Project: Research
-
Creating an evidence base for clinical care: A randomized controlled study examining the efficacy of the low FODMAP diet for the relief of gastrointestinal symptoms in endometriosis.
Muir, J., Burgell, R., Varney, J., Moore, J., Morrison, M. & Fisher, J.
1/06/20 → 31/05/25
Project: Research
-
A 46-week, Double-blind, Placebo-controlled, Phase 3 Study with a 6-week Randomized-withdrawal Period to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis.
Burgell, R. & McKenzie, J.
26/03/20 → 31/12/25
Project: Research
-
Centre for Research Excellence in Digestive Health
Talley, N., Holtmann, G. J., Walker, M. M., Jones, M., Morrison, M., Keely, S., Gibson, P., Chan, S., Tack, J. & Coombes, J. S.
1/11/19 → 31/10/24
Project: Research
-
A Phase 3, Multinational, Double-Blind, Randomized, Placebo-Controlled Study of MGL-3196 (resmetirom) in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis to Resolve NASH and Reduce Progression to Cirrhosis and/or Hepatic Decompensation. Clinical study No. MGL-3196-11.
24/10/19 → 31/12/24
Project: Research
-
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis.
Burgell, R. & Hogg, J.
9/09/19 → 31/12/24
Project: Research